Mariliis Ott1, Lichen Jing, Lazaro Lorenzo, Jean-Laurent Casanova, Shen-Ying Zhang, David M Koelle. 1. From the *Department of Medicine, University of Washington, Seattle, Washington; †Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U1163, University Paris Descartes, Imagine Institute, Paris 75015, France; ‡St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, New York; §Department of Laboratory Medicine, University of Washington, ¶Department of Global Health, University of Washington, ‖Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, and **Benaroya Research Institute, Seattle, Washington.
Abstract
BACKGROUND: Herpes simplex encephalitis (HSE) after primary herpes simplex virus (HSV)-1 infection can occur in children due to inborn errors of cell-intrinsic immunity in the central nervous system. Paradoxically, symptomatic mucocutaneous HSV-1 recurrences are rare survivors of childhood HSE. T-cell-acquired immunity is thought to be involved in control of recurrent mucocutaneous HSV infection. We thus tested HSV-1-specific immunity in HSE survivors. METHODS: We obtained serum and peripheral blood mononuclear cells (PBMCs) from participants a median of 13.5 years after HSE. HSV-1 and HSV-2 IgG was detected by type-specific immunoblot. PBMCs from subjects passing quality control criteria were tested using enzyme-linked immunospot assay for CD4 interferon-γ responses with an HSV-1 lysate and for CD8 responses using pooled synthetic HSV-1 peptide CD8 T-cell epitopes. Healthy adult PBMCs were used to standardize assays and as comparators. RESULTS: All participants were HSV-1 seropositive. Most (23/24) HSE survivors had human leukocyte antigen class I types matching the human leukocyte antigen restriction of the pooled peptides. We detected HSV-specific CD8 T-cell responses in 14 of 24 (58%) HSE survivors and in 9 of 9 healthy HSV-1 seropositive adults. HSV-specific CD4 T-cell responses were present in all 5 HSE subjects tested and in 8 of 9 healthy adults. Response magnitudes were overlapping between subject groups. CONCLUSIONS: The defects in cell-intrinsic immunity leading to failure to control primary central nervous system HSV-1 infection do not preclude the acquisition of specific immunity or the control of recurrent mucocutaneous HSV infections. The rarity and lack of severe or recurrent mucocutaneous HSV infection in survivors of childhood HSE corresponds with intact adaptive T-cell immunity.
BACKGROUND: Herpes simplex encephalitis (HSE) after primary herpes simplex virus (HSV)-1infection can occur in children due to inborn errors of cell-intrinsic immunity in the central nervous system. Paradoxically, symptomatic mucocutaneous HSV-1 recurrences are rare survivors of childhood HSE. T-cell-acquired immunity is thought to be involved in control of recurrent mucocutaneous HSV infection. We thus tested HSV-1-specific immunity in HSE survivors. METHODS: We obtained serum and peripheral blood mononuclear cells (PBMCs) from participants a median of 13.5 years after HSE. HSV-1 and HSV-2 IgG was detected by type-specific immunoblot. PBMCs from subjects passing quality control criteria were tested using enzyme-linked immunospot assay for CD4 interferon-γ responses with an HSV-1 lysate and for CD8 responses using pooled synthetic HSV-1 peptide CD8 T-cell epitopes. Healthy adult PBMCs were used to standardize assays and as comparators. RESULTS: All participants were HSV-1 seropositive. Most (23/24) HSE survivors had human leukocyte antigen class I types matching the human leukocyte antigen restriction of the pooled peptides. We detected HSV-specific CD8 T-cell responses in 14 of 24 (58%) HSE survivors and in 9 of 9 healthy HSV-1 seropositive adults. HSV-specific CD4 T-cell responses were present in all 5 HSE subjects tested and in 8 of 9 healthy adults. Response magnitudes were overlapping between subject groups. CONCLUSIONS: The defects in cell-intrinsic immunity leading to failure to control primary central nervous system HSV-1 infection do not preclude the acquisition of specific immunity or the control of recurrent mucocutaneous HSV infections. The rarity and lack of severe or recurrent mucocutaneous HSV infection in survivors of childhood HSE corresponds with intact adaptive T-cell immunity.
Authors: Lichen Jing; Jürgen Haas; Tiana M Chong; Joseph J Bruckner; Greg C Dann; Lichun Dong; Joshua O Marshak; Christopher L McClurkan; Tori N Yamamoto; Susanne M Bailer; Kerry J Laing; Anna Wald; Georges M G M Verjans; David M Koelle Journal: J Clin Invest Date: 2012-01-03 Impact factor: 14.808
Authors: Francisco A Bonilla; David A Khan; Zuhair K Ballas; Javier Chinen; Michael M Frank; Joyce T Hsu; Michael Keller; Lisa J Kobrynski; Hirsh D Komarow; Bruce Mazer; Robert P Nelson; Jordan S Orange; John M Routes; William T Shearer; Ricardo U Sorensen; James W Verbsky; David I Bernstein; Joann Blessing-Moore; David Lang; Richard A Nicklas; John Oppenheimer; Jay M Portnoy; Christopher R Randolph; Diane Schuller; Sheldon L Spector; Stephen Tilles; Dana Wallace Journal: J Allergy Clin Immunol Date: 2015-09-12 Impact factor: 10.793
Authors: David W Kimberlin; Richard J Whitley; Wen Wan; Dwight A Powell; Gregory Storch; Amina Ahmed; April Palmer; Pablo J Sánchez; Richard F Jacobs; John S Bradley; Joan L Robinson; Mark Shelton; Penelope H Dennehy; Charles Leach; Mobeen Rathore; Nazha Abughali; Peter Wright; Lisa M Frenkel; Rebecca C Brady; Russell Van Dyke; Leonard B Weiner; Judith Guzman-Cottrill; Carol A McCarthy; Jill Griffin; Penelope Jester; Misty Parker; Fred D Lakeman; Huichien Kuo; Choo Hyung Lee; Gretchen A Cloud Journal: N Engl J Med Date: 2011-10-06 Impact factor: 91.245
Authors: Ruchi Srivastava; Arif A Khan; Doran Spencer; Hawa Vahed; Patricia P Lopes; Nhi Thi Uyen Thai; Christine Wang; Thanh T Pham; Jiawei Huang; Vanessa M Scarfone; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed Journal: J Immunol Date: 2015-01-23 Impact factor: 5.422
Authors: Lena Schleede; Wolfgang Bueter; Sara Baumgartner-Sigl; Thomas Opladen; Katharina Weigt-Usinger; Susanne Stephan; Martin Smitka; Steffen Leiz; Olaf Kaiser; Verena Kraus; Andreas van Baalen; Heino Skopnik; Hans Hartmann; Kevin Rostasy; Thomas Lücke; Ulrike Schara; Martin Häusler Journal: J Child Neurol Date: 2013-01-16 Impact factor: 1.987
Authors: Mackenzie M Shipley; Daniel W Renner; Mariliis Ott; David C Bloom; David M Koelle; Christine Johnston; Moriah L Szpara Journal: J Infect Dis Date: 2018-07-13 Impact factor: 5.226